{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:27:51Z","timestamp":1777591671074,"version":"3.51.4"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Treatment option decisions for low-risk squamous cell carcinoma in situ (SCCIS) are hampered by a paucity of management-type\u2013specific outcomes data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>Describe SCCIS tumor outcomes managed by watchful waiting and risk factors associated with poor cancer outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>Retrospective cohort study. Setting: Single academic hospital in a rural setting. Patients: Adults with SCCIS diagnosed between January 01, 2014, and December 31, 2016. Main Outcomes and Measures: Hazard ratios (HRs) for local recurrence (LR), nodal metastases (NM), distant metastases (DM), and disease-specific death (DSD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>A total of 411 consecutive SCCIS tumors that were considered clinically resolved at follow-up and managed with watchful waiting were included. Seventeen tumors recurred locally. No instances of NM, DM, or DSD were identified. Multivariate analysis found that solid-organ transplant recipient status conferred the highest risk of local recurrence [HR, 9.979 (95% CI, 2.249\u201339.69)]. Additional risk factors predicting LR include anatomic location on the vermilion lip or ear [HR, 9.744 (95% CI, 1.420\u201369.28)], anatomic location on the head and neck [HR, 6.687 (95% CI, 1.583\u201336.15)], and a biopsy with tumor extending to the deep edge [HR, 6.562 (95% CI, 1.367\u201339.04)].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Watchful waiting for SCCIS with a clinically resolved biopsy site has a local recurrence rate of 4%.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004202","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T13:00:06Z","timestamp":1715259606000},"page":"710-713","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Oncologic Outcomes for Squamous Cell Carcinoma In Situ With a Clinically Resolved Biopsy Site Managed by Watchful Waiting"],"prefix":"10.1097","volume":"50","author":[{"given":"Sam","family":"Logan","sequence":"first","affiliation":[{"name":"College of Medicine, The University of Vermont, Burlington, Vermont;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah J.","family":"Porter","sequence":"additional","affiliation":[{"name":"Division of Dermatology, The University of Vermont, Burlington, Vermont;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Lowry","sequence":"additional","affiliation":[{"name":"College of Medicine, The University of Vermont, Burlington, Vermont;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cari","family":"Carpenter","sequence":"additional","affiliation":[{"name":"College of Medicine, The University of Vermont, Burlington, Vermont;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Seward","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of Vermont, Burlington, Vermont"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Holmes","sequence":"additional","affiliation":[{"name":"Division of Dermatology, The University of Vermont, Burlington, Vermont;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Goldman","sequence":"additional","affiliation":[{"name":"Division of Dermatology, The University of Vermont, Burlington, Vermont;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie R.","family":"Bui","sequence":"additional","affiliation":[{"name":"Division of Dermatology, The University of Vermont, Burlington, Vermont;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaad.2021.07.067","article-title":"Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: a systematic review and meta-analysis","volume":"87","author":"Stewart","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bjd.12766","article-title":"British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014","volume":"170","author":"Morton","year":"2014","journal-title":"Br J Dermatol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2340\/00015555-2175","article-title":"A retrospective study of treatment of squamous cell carcinoma in situ","volume":"96","author":"\u00d6vermark","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"R4-20250731","first-page":"878","article-title":"Bowen's Disease: a four-year retrospective review of epidemiology and treatment at a university center","volume":"34","author":"Hansen","year":"2008","journal-title":"Dermatol Surg"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/dsu.12088","article-title":"Evaluation of residual tumor from Mohs micrographic specimens of clinically resolved preoperative biopsy sites","volume":"39","author":"Kwon","year":"2013","journal-title":"Dermatol Surg"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ucl.2017.07.005","article-title":"Contemporary active surveillance: candidate selection, follow-up tools, and expected outcomes","volume":"44","author":"Perlis","year":"2017","journal-title":"Urol Clin North Am"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/dsu.12056","article-title":"Incidence of residual nonmelanoma skin cancer in excisions after shave biopsy","volume":"39","author":"Grelck","year":"2013","journal-title":"Dermatol Surg"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaad.2020.08.089","article-title":"Cutaneous squamous cell carcinoma of the forearm: clinical features and outcomes at a single academic tertiary care center in a rural setting","volume":"85","author":"Johnston","year":"2021","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:00:25Z","timestamp":1753999225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004202","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}